ODTX · NASDAQ
Odyssey Therapeutics (ODTX) Stock Price & Fundamentals
Odyssey Therapeutics (ODTX) closed at $577.05 on Oct 9, 2026, down 0.06% from the previous close of $577.42.
Share price, past year
1Y +25.14%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $577.05 |
| Sep 30, 2026 | $555.92 |
| Aug 31, 2026 | $587.57 |
| Jul 31, 2026 | $544.93 |
| Jun 30, 2026 | $533.72 |
| May 29, 2026 | $501.86 |
| Apr 30, 2026 | $470.31 |
| Mar 31, 2026 | $457.48 |
| Feb 27, 2026 | $450.58 |
| Jan 30, 2026 | $431.09 |
| Dec 31, 2025 | $451.72 |
| Nov 28, 2025 | $451.15 |
| Oct 31, 2025 | $457.92 |
Key statistics
- Market cap
- $27.64B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 47.9M
- Dividend yield
- —
- 52-week range
- $427.29 – $589.47
Odyssey Therapeutics's market cap is $27.64B, based on a share price of $577.05 and 47.9M shares outstanding as of Jun 30, 2026.
Financials
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $0.00 | −$52.79M | −$1.74 |
| Q1 FY2026ended Mar 31, 2026 | $0.00 | −$38.26M | −$6.77 |
| Q2 FY2025ended Jun 30, 2025 | $959.00K | −$41.24M | −$29.54 |
| Q1 FY2025ended Mar 31, 2025 | $1.92M | −$38.44M | −$39.37 |
Company profile
- Name
- Odyssey Therapeutics, Inc.
- Ticker
- ODTX
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Biological Products, (No Diagnostic Substances)
- Headquarters
- 51 Sleeper Street, Boston, MA 02210
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001882782
Recent SEC filings
- Sep 9, 2026
- Aug 6, 2026
- Aug 4, 2026
- Jun 23, 2026
- Jun 17, 2026
- Jun 17, 2026
- May 11, 2026
Frequently asked questions
What is Odyssey Therapeutics's stock price?
Odyssey Therapeutics (ODTX) closed at $577.05 on Oct 9, 2026, down 0.06% from the previous close of $577.42.
What is Odyssey Therapeutics's market cap?
Odyssey Therapeutics's market cap is $27.64B, based on a share price of $577.05 and 47.9M shares outstanding as of Jun 30, 2026.
Sources and methodology
Fundamentals come from Odyssey Therapeutics, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures